Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management
Molecules · 2023
DOI: 10.3390/molecules28052237 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Mohsin Kazi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia. Hauptthemen laut MEDLINE: Breast Neoplasms, Lung Neoplasms, Nanoparticles. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia.
Abstract (Originalsprache)
Oral anticancer therapy mostly faces the challenges of low aqueous solubility, poor and irregular absorption from the gastrointestinal tract, food-influenced absorption, high first-pass metabolism, non-targeted delivery, and severe systemic and local adverse effects. Interest has been growing in bioactive self-nanoemulsifying drug delivery systems (bio-SNEDDSs) using lipid-based excipients within nanomedicine. This study aimed to develop novel bio-SNEDDS to deliver antiviral remdesivir and baricitinib for the treatment of breast and lung cancers. Pure natural oils used in bio-SNEDDS were analyzed using GC-MS to examine bioactive constituents. The initial evaluation of bio-SNEDDSs were performed based on self-emulsification assessment, particle size analysis, zeta potential, viscosity measurement, and transmission electron microscopy (TEM). The single and combined anticancer effects of remdesivir and baricitinib in different bio-SNEDDS formulations were investigated in MDA-MB-231 (breast cancer) and A549 (lung cancer) cell lines. The results from the GC-MS analysis of bioactive oils BSO and FSO showed pharmacologically active constituents, such as thymoquinone, isoborneol, paeonol and p-cymenene, and squalene, respectively. The representative F5 bio-SNEDDSs showed relatively uniform, nanosized (247 nm) droplet along with acceptable zeta potential values (+29 mV). The viscosity of the F5 bio-SNEDDS was recorded within 0.69 Cp. The TEM suggested uniform spherical droplets upon aqueous dispersions. Drug-free, remdesivir and baricitinib-loaded bio-SNEDDSs (combined) showed superior anticancer effects with IC50 value that ranged from 1.9–4.2 µg/mL (for breast cancer), 2.4–5.8 µg/mL (for lung cancer), and 3.05–5.44 µg/mL (human fibroblasts cell line). In conclusion, the representative F5 bio-SNEDDS could be a promising candidate for improving the anticancer effect of remdesivir and baricitinib along with their existing antiviral performance in combined dosage form.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Vitiligo Research Chair, Department of Dermatology, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
- Kayyali Research Chair for Pharmaceutical Industries, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmaceutical Chemistry, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Dermatology, College of Medicine, King Saud University, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Mohsin Kazi, Ahmad Abdul-Wahhab Shahba
Förderung
- King Saud University
- Deputyship for Research and Innovation, Ministry of Education in Saudi Arabia
Zitieren
APA
Kazi, M., Alanazi, Y., Kumar, A., Shahba, A. A., Rizwan Ahamad, S., & Alghamdi, K. M. (2023). Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management. Molecules. https://doi.org/10.3390/molecules28052237
Vancouver
Kazi M, Alanazi Y, Kumar A, Shahba AA, Rizwan Ahamad S, Alghamdi KM. Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management. Molecules. 2023. doi:10.3390/molecules28052237
BibTeX
@article{Kazi2023,
author = {Kazi, Mohsin and Alanazi, Yousef and Kumar, Ashok and Shahba, Ahmad Abdul-Wahhab and Rizwan Ahamad, Syed and Alghamdi, Khalid M},
title = {Oral Bioactive Self-Nanoemulsifying Drug Delivery Systems of Remdesivir and Baricitinib: A Paradigmatic Case of Drug Repositioning for Cancer Management},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28052237}
}
EUVIMED